In this issue of European Urology Oncology, Woo and colleagues [1] review the diagnostic performance of the recently introduced Vesical Imaging-Reporting and Data System (VI-RADS). The aim of this scoring system is to standardize the acquisition and reporting of multiparametric magnetic resonance imaging (mpMRI) data (which combines anatomic sequences of T1- and T2-weighted imaging, and functional sequences of dynamic contrast-enhanced and diffusion-weighted imaging) for bladder cancer staging, with a focus on differentiation between muscle-invasive bladder cancer (MIBC) and non-MIBC (NMIBC) [2].